Capstone Therapeutics Corp
OTC:CAPS

Watchlist Manager
Capstone Therapeutics Corp Logo
Capstone Therapeutics Corp
OTC:CAPS
Watchlist
Price: 0.74 USD -2.63% Market Closed
Market Cap: 6.1m USD

Wall Street
Price Targets

CAPS Price Targets Summary
Capstone Therapeutics Corp

Wall Street analysts forecast CAPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
719% Upside
Average
Price Target
6.12 USD
727% Upside
Highest
Price Target
6.3 USD
751% Upside
Capstone Therapeutics Corp Competitors:
Price Targets
4BB
4Basebio PLC
182% Upside
ACAD
ACADIA Pharmaceuticals Inc
7% Upside
6628
Transcenta Holding Limited
586% Upside
TVTX
Travere Therapeutics Inc
5% Upside
301207
Hualan Biological Bacterin Inc
3% Upside
CMPX
Compass Therapeutics Inc.
144% Upside
GILD
Gilead Sciences Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Capstone Therapeutics Corp

Revenue forecast
is not available for
Capstone Therapeutics Corp

Operating Income
Forecast

Operating Income Estimate
Capstone Therapeutics Corp

Operating Income forecast
is not available for
Capstone Therapeutics Corp

Net Income
Forecast

Net Income Estimate
Capstone Therapeutics Corp

Net Income forecast
is not available for
Capstone Therapeutics Corp
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPS's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top